ARTICLE | Company News
Movetis sales and marketing update
February 1, 2010 8:00 AM UTC
Movetis launched Resolor prucalopride in Germany to treat chronic constipation in women not receiving adequate relief from laxatives. Movetis plans to launch the serotonin (5-HT4) receptor agonist i...